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Abstract: Quality control standardizations of the various medicinal plants used in 
traditional medicine is becoming more important today in view of the commercialization of 
formulations based on these plants. An attempt at standardization of Cassia spectabilis leaf 
has been carried out with respect to authenticity, assay and chemical constituent analysis. 
The authentication involved many parameters, including gross morphology, microscopy of 
the leaves and functional group analysis by Fourier Transform Infrared (FTIR) 
spectroscopy. The assay part of standardization involved determination of the minimum 
inhibitory concentration (MIC) of the extract which could help assess the chemical effects 
and establish curative values. The MIC of the C. spectabilis leaf extracts was investigated 
using the Broth Dilution Method. The extracts showed a MIC value of 6.25 mg/mL, 
independent of the extraction time. The chemical constituent aspect of standardization 
involves quantification of the main chemical components in C. spectabilis. The GCMS 
method used for quantification of 2,4-(1H,3H)-pyrimidinedione in the extract was rapid, 
accurate, precise, linear (R2 = 0.8685), rugged and robust. Hence this method was suitable 
for quantification of this component in C. spectabilis. The standardization of C. spectabilis 
is needed to facilitate marketing of medicinal plants, with a view to promoting the export 
of valuable Malaysian Traditional Medicinal plants such as C. spectabilis. 
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1. Introduction  
Herbal medicines are the therapeutic experiences of generations of practicing physicians of 
traditional medicine over hundreds of years and they are known to be oldest health care products that 
have been used by mankind all over the world to treat various types of ailments [1]. Herbal traditional 
medicine has gained considerable momentum worldwide during the past decade. An important factor, 
which can contribute to the consistent quality of herbal products, is to have adequate standardization. 
Due to the natural heterogeneity, the quality of herbal starting materials obtained from wild collections 
shows great fluctuations. Thus, standardization of herbal products has been extensively promoted 
during the last years. Standardization is defined by the American Herbal Products Association as “… 
the body of information and controls necessary to produced materials of reasonable consistency. This 
is achieved through minimizing the inherent variation of natural product composition through quality 
assurance practices applied to agricultural and manufacturing processes”[2]. For standardization and 
quality assurance purposes, the following three attributes are must be verified: authenticity, purity and 
assay [3]. Hence, in this paper we report an attempt for the standardization of Cassia spectabilis leaf 
with respect to authenticity, assay and chemical constituent analysis. 
The genus Cassia, comprising about 600 species widely distributed worldwide is well known for its 
diverse biological and pharmacological properties [4]. Cassia spectabilis (sin Senna spectabilis) (DC) 
Irwin et Barn (Leguminosae) is widely grown as an ornamental plant in tropical and subtropical areas, 
and has been commonly used in traditional medicine for many years. It has also been used in 
traditional Brazilian medicine for the treatment of flu and cold, as a laxative and purgative [5]. Other 
actions like antifungal [6], antibacterial [7], and antioxidant [8] have been reported. The plant is 
collected from the wild sources and varies in constituents and efficacy due to its geographical 
diversity. Improper collection and storage condition lead to the deterioration of the raw material. 
Keeping in view the abovementioned problems, it was important to standardize the leaves of C. 
spectabilis to establish a quality and identity profile of the plant for the purpose of overall quality 
assurance of this medically important plant. Since there are no reports in the literature regarding the 
standardization of C. spectabilis leaves, in the present investigation an attempt has been made to 
standardize them by using macroscopic and microscopic characteristics, authenticity, biological 
activity assay and chemical constituent analysis.  
 
2. Results and Discussion 
 
2.1. Herbarium 
Since, plant classifications are constantly changing, the verification of the authenticity of the 
specimens using the herbarium is becoming an increasingly important step. Voucher specimens help 
cross-reference these changes to previous plant materials. Hence, in this study a C. spectabilis 
herbarium was prepared (Figure 1). C. spectabilis is a recognized source of useful chemicals for the 
pharmaceutical industries, but authenticity of specimens is important for these industries to avoid the 
acceptance of wrong plant materials for extracting actives, potentially resulting in a loss of billions of 
dollars. Therefore, the correctly identified herbarium specimens can be used for comparison of future 
C. spectabilis collections. In addition, using a herbarium specimen will allow the study of 
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morphological or anatomical details that will help identify field collected plant specimens in the sterile 
or non-reproductive condition.  
Figure 1. The Cassia spectabilis herbarium. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2. Macroscopy and microscopy of leaf 
 
Most of the regulatory guidelines and pharmacopoeias suggest macroscopic and microscopic 
evaluation of the botanical materials for standardization [9]. Thereby, in this study a macroscopic and 
microscopic evaluation of the leaf material was done as the leaf extract was to be used in our 
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subsequent anticandidal biofilm activity study. The leaves of C. spectabilis were subjected to 
macroscopical examination and observations were recorded. The proper examination of the leaves was 
carried out under sunlight and artificial light sources similar to daylight. The leaves of C. spectabilis 
were observed to be green, pinnate leaves, 7–15 pairs of leaflets, 2 to 3.6 inches long (5–9 cm), entire 
margin with fuzzy undersides. A photomicrograph of the identifying features of the leaf is shown in 
Figure 2. Transverse section of the leaf of C. spectabilis through the midrib revealed the presence of 
upper epidemis with straight anticlinal walls and elongated palisade cells underneath. There are 
conspicuous spongy parenchymal cells on the lower surface and in between were the xylem and 
phloem vessels. 
Figure 2. Transverse section of the leaf of C. spectabilis. 
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2.3. Fourier Transform Infrared (FTIR) fingerprinting 
 
The use of FTIR fingerprinting for herbal extract tends to focus on identification and assessment of 
the stability of the chemical constituents’ functional groups as observed by FTIR analysis.  The results 
of FTIR fingerprint for the methanolic extract is shown in Figure 3. The results of functional group 
analysis using FTIR demonstrated that the existence of various characteristic functional groups in the 
C. spectabilis extract (Figure 3). Eight major peaks in the range 700–1,200 cm-1, 1,139–2,000 cm-1 and 
2,043–4,000 cm-1 were observed in the FTIR spectra. Therefore, for future C. spectabilis methanolic 
extraction this FTIR spectrum can be used for comparison. Obviously, the FTIR fingerprint can be 
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used to ensure that the functional groups in the new extract are present in reproducible manner 
although a new extraction has been done. As a result, FTIR fingerprints assist the manufacturer in 
controlling and assuring the consistency and the standard quality of the extract in each phase of  
an extraction. 
Figure 3. FTIR spectra of methanolic extract of Cassia spectabilis (KBr disc), cm-1. 
 
 
 
 
 
 
 
 
 
 
2.4. Minimum inhibitions concentration (MIC) 
 
Consistency in the biological activity is an essential requirement for the effective use of therapeutic 
agents.This consistency ensures that the extract retains its therapeutic parameters throughout the shelf 
life assigned to the extract. Hence, studies that confirm that the extract retains its efficacy and 
biological activity are crucially important before it’s use by the pharmaceutical industries. Hence, in 
this study the antifungal activity was used for this purpose by determining the MIC value.  The MIC of 
the C. spectabilis leaves extracts was investigated by using Broth Dilution Method against pathogenic 
yeast Candida albicans. The extracts showed a MIC value of 6.25 mg/mL and retained the value for 
different extraction times (Table 1). 
Table 1. Minimum inhibitions concentration value of Cassia spectabilis. 
Extraction time 
(Month) 
MIC Value (mg/mL) 
1 
2 
3 
6.25 
6.25 
6.25 
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2.5. Chemical constituent standardization 
 
Along with authentication of species identity and assay, chemical constituent standardization is also 
required for quality control in the use of plant materials for pharmaceutical purposes. In this study the 
C. spectabilis leaf extract was identified as an extract containing no constituents documented as being 
determinant or relevant for efficacy, or as having any pharmacological or clinical relevance. In this 
case, chemically defined constituent (markers) without known therapeutic activity may be used for 
control purposes [1]. These markers may be used to monitor good manufacturing practice or as an 
indication for the content of the extract [1]. A standard curve was plotted using the area of the peak 
obtained in the GCMS chromatogram against the concentration of 2,4-(1H,3H)-pyrimidinedione. The 
GCMS profile and calibration curve of the compound is given in Figures 4 and 5. This could be 
applied for the standardization and validation of C. spectabilis leaf extract in terms of 2,4-(1H,3H)-
pyrimidinedione as a chemical marker [10]. According to Lazarowych and Pekos [10], chemical and 
chromatographic techniques are currently used for identification and assessment of chemical 
constituents of medicinal plants. The most common techniques are high performance liquid 
chromatography (HPLC), thin layer chromatography (TLC), and gas chromatography (GC) [10]. 
Chromatographic fingerprints and marker compounds are used as reference standards, which indicate 
the purity, identity, and quality of the herbal drug [10]. 
 
Figure 4. GCMS profile of 2,4-(1H,3H)-pyrimidinedione at retention time 12.57.  
a = 5 mg/mL, b = 10 mg/mL, c = 15 mg/mL, d = 20 mg/mL. 
 
 
a                                                                               b 
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Figure 4. Cont. 
 
 
  
 
Figure 5. Calibration curve of 2,4-(1H,3H)-pyrimidinedione by GCMS. 
 
 
 
 
 
 
 
 
 
 
 
3. Experimental 
 
3.1. Chemicals and reagents  
 
All the chemicals and reagents used were of analytical grade, purchased from Sigma Chemical Co. 
(St Louis, MO, USA) or Merck (Darmstadt, Germany).  
y = 4E+06x - 5E+06
R2 = 0.8685
0
10000000
20000000
30000000
40000000
50000000
60000000
70000000
80000000
90000000
0 5 10 15 20 25
Concentration (mg/ml)
A
re
a 
(%
)
 
c                                                                             d           
Molecules 2010, 15  
 
 
3418
3.2. Plant sample 
 
A sample of C. spectabilis was collected in April 2009, from Universiti Sains Malaysia campus, 
Pulau Pinang, Malaysia and authenticated at the Herbarium of the School of Biological Sciences, 
Universiti Sains Malaysia, Pulau Pinang, Malaysia where a sample (voucher number 11033) has been 
deposited. 
 
3.3. Qualitative investigation 
 
The macroscopic features of the fresh leaves were determined using the methods of Evans [11]. 
Anatomical sections, a surface preparation of the fresh leaves sample for the microscopy was carried 
out according to methods outlined by Brain and Turner [12]. Morphological examination of the C. 
spectabilis leaf specimen was used to identify the leaf structures. Leaf tissue was fixed in 10% 
buffered formalin. After fixation, the tissue was dehydrated in a graded series of alcohols, cleared in 
xylene and embedded in paraffin wax. Multiple 5 mm sections from the block were mounted on slides 
and stained with 0.5% methylene blue and examined under a light microscope. 
 
3.4. FTIR analytical methods 
 
The methanol extracts of C. spectabilis was mixed with KBr salt, using a mortar and pestle, and 
compressed into a thin pellet. Infrared spectra were recorded on a Shimadzu FTIR Spectrometer 8000 
series, between 4,000–500 cm-1. All determinations were performed in triplicate [13]. 
 
3.5. Determination of MIC of leave extract 
 
The serial tube dilution technique was used to determine the MIC of the extract against Candida 
albicans. A stock solution of the plant extract was prepared to give a concentration of 200 mg/mL. In a 
serial dilution technique, 5 mL of the prepared stock solution was transferred to a test tube containing 
5 mL of potato dextrose broth medium to give concentration of 100 mg/mL, from which 5 mL was 
transferred to another test tube containing 5 mL of potato dextrose broth medium to give 
concentrations ranging from 100 mg/mL to 0.1 mg/mL. After the preparation of the Candida albicans 
suspensions (107 organisms per mL), 500 µL of the yeast suspensions was added to each broth 
dilution. After 24 h incubation at 37 ºC, the tubes were examined for growth. The MIC of the extract 
was taken as the lowest concentration that shows no growth. Growth was observed in those tubes 
where the concentration of the extract is below the inhibitory level and the broth medium was turbid 
(cloudy) when observed [14].  
 
3.6. Gas chromatography–mass spectrometry (GC–MS) analysis 
 
The GC/MS analysis was done on a thermo gas chromatograph - mass spectrometer (model 
Shimadzu 2010) equipped with DB-5 capillary column (30 m long. 0.25 mm i.d., film thickness  
0.25 μm). The column temperature program was 50 ºC for 6 min, with 5 ºC per min increases to  
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250 ºC; which was maintained for 30 min. The carrier gas was helium at a flow rate of 1 mL/min 
(splitless mode). The detector and injector temperatures were both maintained at 250 ºC. The 
quadrupole mass spectrometer was scanned over the range 28–400 amu at 1 scan s-1, with an ionising 
voltage of 70 eV, an ionisation current of 150 Μa and an ion source temperature of 200 ºC [15]. In 
order to determine the Kovats index of the components, a mixture of alkenes (C9–C24) was added to 
the crude extract before injecting in the GC–MS equipment and analysed under the same conditions as 
above. The compounds were identified by computer searches in the commercial libraries of the 
National Institute of Standard and Technology (NIST) and by their Kovats retention indexes.  
4. Conclusions 
Standardization of medicinal plants plays an important role in the development of pharmaceutical 
drugs from these plants because standardization establishes quality and identity profile of the plant for 
the purpose of overall quality assurance. The results obtained from this study are encouraging and will 
be used as a reference data for the standardization of C. spectabilis and formulations containing C. 
spectabilis leaf extract as a main ingredient.  
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